What is your position on Apple today? Do you think the recent weakness has created a good opportunity to trade the stock? Would you not think the stock regain its (10%) loss following the release of its Q1 after the close tomorrow?
Q: MMM has fallen from grace, I presume from reduced guidance. However, I see increasing and steady dividends, a well managed business, good margins, major buy backs continuing, etc., etc.
Is the decline in price simply b/c investors are wanting more growth? Would you consider MMM a good buy today?
Q: A follow up to my question earlier today. I am assuming that the shorts are betting on the inability of the company to successfully cope with a higher churn rate. Do you agree? If not, why is the stock being shorted? What are your thoughts regarding the management team and the business model. Do you see tangible signs that the company is , and will be able to continue, coping with a higher churn rate?
Q: Edwards, a US company that you likely do not follow, has developed an minimally invasive medical device and procedure for replacing faulty valves in humans. This procedure has many advantages, includinding cost and recovery time, over the open heart procedure. While there is competition in this market Edwards appears to be growing the stock has not performed well recently and I am down about 8%. I am considering selling if my loss reaches 10%.
Would you please give me you opinion of this company if you follow it t all?
With appreciation,
Ed
Q: I think you present a sensible outlook however I wonder about the Portfolios? The Balanced Equity is my interest but with 27 stocks it is to big. To do a decent size (2%) my target is $16000.00 per stock. Should I cherry pick? Would like your recommendation. Regards, Burke Purdon
Q: Please list your top 3 Canadian Companies for 5+ years hold.
My present portfolio is primarily US with equal amounts of GOOG, AMZN, BRKB, BABA, TCEHY.
Q: Hi, Any comments on Shopify earnings release and a beat on EPS and Revenue ? Does it put the Citron thesis and market skepticism to rest, in your view ? Thanks
Q: Last week there were a couple days with PHO.V where there was more than triple the normal volume of buying. Does this indicate that institutional investors are buying up the stock and is therefore a buy signal for me?
If it's institutional investors, why would they be such large buyers now on no news? Do they have access to information that we don't such as the quarterly results coming out?
Q: I can't seem to come to a decision.
Should I continue to hold XHY for the long term (+5 yrs)considering the direction of investment grade bond prices? Should I buy more as high yield prices drop?
This represents less than one percent of my holdings.
Your thoughts please.
Dave
Q: I am down 60% on SGY but would like to keep it because in a recovery, I think it would be a good one to have. However, I need some capital losses to offset some capital gains. I don't want to sell it and wait 30 days to buy it back because it may move up during that time. To avoid the 30 day waiting period and still get some capital loss, could I buy more share now and then sell half in a few days? The loss would not be as high because of the adjusted ACB but it would work okay for me. Would this action attract the 'superficial loss' rule or is this a way around it?
Q: Hello 5i team. I have NFI New Flyer and XTC Exco presently as industrials. I would like to add a bit of money to my industrials exposure and I am asking for your direction or recommendation either from the 5i's portfolios or outside of. I prefer to stay in the Canadian area. Risk is not a major factor for me in regards to this selection. Divi's make me a happy but also not a final decision maker. I can simply add to either of the above names also. I have twice as much XTC as I do NFI.
Thank you
You have been a tremendous help to me.
Q: I am a shareholder in Andeavor which announced this morning that it was being acquired in a friendly deal by Marathon Petroleum Corporation. I previously held shares in Western Refining that was in turn acquired by Tesoro, Andeavor's prior name, in a share deal. Marathon is offering $152 a share, payable in cash or shares. I am inclined to take the cash and run (assuming the deal clears antitrust review - note there is a large deal completion discount with Andeavor shares closing at $138 today). Do you have any thoughts on what a prudent course of action would be/would you be more inclined to take the shares or cash? (I hold the shares in a TFSA so no tax payable)
Q: Comments on earnings please. SP has fallen after hours. Do you see any catalyst moving forward or more of a stagnation due to slowing growth,
Thank you